Search clinical trials for: Bepotastine besilate

Total 41 results

Asan Medical Center

Completed

Effects of Second-generation Antihistamine Bepotastine on Cough Outcomes in Cough Patients With Allergic Rhinitis

Cough | Allergic Rhinitis

Korea, Republic of
Laboratorios Poen

Completed

Efficacy and Toxicity of Bepotastine 1,5% PF vs Olopatadine 0,2% With BAK on Allergic Conjunctivitis Treatment

Allergic Conjunctivitis

Argentina
Laboratorios Sophia S.A de C.V.

Completed

Clinical Study for the Evaluation of Safety and Tolerability of PRO-172 Ophthalmic Solution+ (PRO-172)

Tolerability | Safety | Ocular Surface | Ocular Comfort

Mexico
Bausch & Lomb Incorporated

Completed

Bepotastine Besilate Nasal Sprays in the Treatment of Seasonal Allergic Rhinitis (SAR)

Seasonal Allergic Rhinitis

United States
Bausch & Lomb Incorporated

Completed

Safety and Efficacy of Bepotastine Besilate Nasal Spray in the Treatment of Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

United States
Bausch & Lomb Incorporated

Completed

Safety, Pharmacokinetics, and Efficacy of Bepotastine Besilate Nasal Product After Ragweed Pollen Exposure in an Environmental Chamber

Seasonal Allergic Rhinitis

United States
Bausch & Lomb Incorporated

Completed

Bepotastine Besilate-corticosteroid Nasal Spray Combination Compared to Placebo, Bepotastine Besilate Nasal Spray, and Corticosteroid Nasal Spray in the Treatment of Patients With Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

United States
Bausch & Lomb Incorporated

Completed

Safety and Efficacy of Bepotastine Besilate Ophthalmic Solution in Seasonal Allergic Conjunctivitis Patients

Allergic Conjunctivitis

United States
Dong-A ST Co., Ltd.

Completed

Bioequivalence Test of "Dong-a Bepotastine Besilate Tab" and "Twolion Tab"

Healthy

Korea, Republic of
Southern California College of Optometry at Marshall...

Completed

Bepreve vs. Alrex in Subjects With Moderate to Severe Allergic Conjunctivitis

Allergic Conjunctivitis

United States
Mitsubishi Tanabe Pharma Corporation

Completed

A Confirmatory Study of TAU-284 in Pediatric Patients With Atopic Dermatitis

Dermatitis | Atopic

Japan
Alcon Research

Completed

Safety and Efficacy Study of BETOPTIC S 0.25% and Timolol Gel-forming Solution 0.25% and 0.5% in Pediatric Patients With Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma

United States
Mitsubishi Tanabe Pharma Corporation

Completed

A Long-Term Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis

Perennial Allergic Rhinitis

Japan
Mitsubishi Tanabe Pharma Corporation

Completed

The Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis

Perennial Allergic Rhinitis

Japan
Mitsubishi Tanabe Pharma Corporation

Completed

A Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis

Perennial Allergic Rhinitis

Japan
Daewoong Pharmaceutical Co. LTD.

Completed

Drug Interaction Study Between Erdosteine and Bepotastine Besilate in Healthy Adult Volunteers

Healthy
McCabe Vision Center

Completed

Comparing Patient Satisfaction With Pataday or Bepreve

Eye Allergies

United States
HK inno.N Corporation

Completed

A Randomized, Open Label, Three-Treatment, Three-Period, Six-Sequence Crossover Study To Compare Safety and Pharmacokinetic Properties of CJ-30044 and Bepotastine Besilate and To Investigate Food-effect on Pharmacokinetics of CJ-30044 in Healthy Adult Male Volunteers

Healthy

Korea, Republic of
Korea University Anam Hospital
Hanlim Pharm. Co., Ltd.

Completed

PK Comparisons of Bepotastine Besilate 10 mg and Bepotastine Salicylate 9.64 mg

Allergic Rhinitis | Pruritus | Urticaria

Korea, Republic of
Bausch & Lomb Incorporated

Completed

Safety Study for Bepotastine Besilate Ophthalmic Solution in Normal Volunteers

Allergic Conjunctivitis
Bausch & Lomb Incorporated

Completed

Evaluation of the Onset and Duration of Action of Bepotastine Besilate Ophthalmic Solution in Acute Allergic Conjunctivitis

Conjunctivitis, Allergic

United States
Bausch & Lomb Incorporated

Completed

Efficacy and Safety Study of Bepotastine Besilate Ophthalmic Solution in Allergic Conjunctivitis

Allergic Conjunctivitis

United States
Hom, Milton M., OD, FAAO
Bausch & Lomb Incorporated

Unknown

Use of BEPREVE (Bepotastine Besilate Ophthalmic Solution) 1.5% for Allergic Conjunctivitis and Contact Lenses

Allergic Conjunctivitis
North Texas Institute for Clinical Trials

Completed

The Evaluation of Bepreve on the Measurement of Wheal and Flare Response From Histamine Skin Prick Testing

Histamine Responsive Allergy Patients

United States
Second Hospital of Shanxi Medical University

Recruiting

Cardiovascular Protection Conservative Effects of Esketamine Versus µ-opioid Receptor Agonists in General Anesthesia

Opioid Analgesic Adverse Reaction

China
Celgene

Active, not recruiting

A Safety, Tolerability and Preliminary Efficacy Evaluation of CC-90011 Given in Combination With Cisplatin and Etoposide in Subjects With First Line, Extensive Stage Small Cell Lung Cancer

Small Cell Lung Carcinoma

France, Italy, Spain
Celgene

Terminated

A Safety and Efficacy Study of CC-90011 in Participants With Relapsed and/or Refractory Solid Tumors and Non-Hodgkin's Lymphomas

Neoplasms | Lymphoma, Non-Hodgkin

France, Italy, Japan, Spain, United Kingdom
Celgene

Completed

A Safety and Efficacy Study of CC-90011 in Combination With Nivolumab in Subjects With Advanced Cancers

Neoplasms

United States, France, Italy, Poland, Spain, United Kingdom
Celgene

Completed

A Study of CC-90011 and Comparators in Participants With Prostate Cancer

Prostatic Neoplasms

United States
Albany Medical College
Hospital for Special Surgery, New York

Completed

The Effect of Pretreatment for Propionibacterium Acnes on Surgical Site Burden in Shoulder Arthroplasty

Shoulder Arthroplasty

United States
Celgene

Terminated

A Safety, Tolerability and Preliminary Efficacy Study of CC-90011 in Combination With Venetoclax and Azacitidine in R/R Acute Myeloid Leukemia and Treatment-naïve Participants Not Eligible for Intensive Therapy

Leukemia, Myeloid

United States, France, Belgium, Spain
University Hospital, Clermont-Ferrand

Unknown

Treatment of Intracranial Hypertension of Severe Tramatic Brain Injured Patients. Physiopathologic Effects of Neuromuscular Blocking Agents (THIC Cu)

Traumatic Brain Injury | Intracranial Hypertension

France
Takeda

Completed

Candesartan Cilexetil/Amlodipine Besilate Combination Tablets LD, HD Special Drug Use Surveillance "Hypertension: Long-Term Use"

Hypertension
Novartis

Completed

Long Term Study of Valsartan and Amlodipine in Patients With Essential Hypertension (Extension to Study CVAA489A1301)

Hypertension

Japan
Theodor Bilharz Research Institute

Completed

Dexmedetomidine and Desflurane Consumption

Anesthesia

Egypt
National Cancer Institute (NCI)

Completed

Carboxyamidotriazole + RT in Treating Patients Newly Diagnosed Supratentorial GBM

Adult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma

United States
Zhujiang Hospital

Unknown

Effect of Induction and Maintenance of Anesthesia With Etomidate on Hemodynamics and Oxidative Stress in Diabetic Patients

Oxidative Stress | Anesthesia | Hemodynamics
Actavis Inc.

Completed

A Relative Bioavailability Study of Amlodipine Besylate 10 mg Tablets Under Fasting Conditions

Healthy

Canada
Actavis Inc.

Completed

A Relative Bioavailability Study of Amlodipine Besylate 10 mg Tablets Tablets Under Fed Conditions

Healthy

Canada
Assistance Publique Hopitaux De Marseille
GlaxoSmithKline

Completed

Systematic Early Use of Neuromuscular Blocking Agents in ARDS Patients

ARDS

France
The Japanese Society of Hypertension

Unknown

Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial of Cardiovascular Events in High-Risk Hypertensive Patients

Cardiovascular Diseases | Hypertension

Japan

3

Subscribe